JPRN-UMIN000006393已完成未知
Cross-sectional study of second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC. - Second-line chemotherapy administration for patients with advanced NSCLC, who completed platinum-based "Hyojun" (standard) doublet, In the follow-up period, and at recurrence.(SAPPHIRE)
SAPPHIRE Executive committee0 个研究点目标入组 750 人开始时间: 2011年9月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Recurrent NSCLC patients who had undergone adjuvant platinum based chemotherapy. 2)Active double cancer.
研究者
相似试验
已完成
不适用
Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast CancerHormone Receptor Positive Breast CarcinomaHER2-negative Breast CancerAdvanced Breast CancerNCT05173103University of Milano Bicocca254
招募中
不适用
Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: a Real-world StudyGastrointestinal Stromal TumorsNCT05440357Xinhua Zhang, MD100
终止
不适用
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)Graft Versus Host DiseaseNCT02151539Vanderbilt-Ingram Cancer Center19
进行中（未招募）
2 期
JACCRO CC-16colorectal cancerJPRN-jRCTs061180002TSUJI Akihito90
招募中
2 期
Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsAdvanced Metastatic Pancreatic CancerNCT06662006The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School56